• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型奥密克戎变种适应性优势的全球估计。

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron.

作者信息

van Dorp Christiaan, Goldberg Emma, Ke Ruian, Hengartner Nick, Romero-Severson Ethan

机构信息

Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York NY, USA.

Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos NM, USA.

出版信息

medRxiv. 2022 Jun 16:2022.06.15.22276436. doi: 10.1101/2022.06.15.22276436.

DOI:10.1101/2022.06.15.22276436
PMID:35734094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9216718/
Abstract

New variants of SARS-CoV-2 show remarkable heterogeneity in their relative fitness both over time and space. In this paper we extend a previously published model for estimating the selection strength for new SARS-CoV-2 variants to a hierarchical, mixed-effects, renewal equation model. This formulation allows us to globally estimate selection effects at different spatial levels while controlling for complex patterns of transmission and jointly inferring the effects of unit-level covariates in the spatial heterogeneity of SARS-CoV-2 selection effects. Applying this model to the spread of Omicron in 40 counties finding evidence for very strong (64%) but very heterogeneous selection effects at the country level. We further considered different measures of vaccination levels and measures of recent population-level infection as possible explanations. However, none of those variables were found to explain a significant proportion of the heterogeneity in country-level selection effects. We did find a significant positive correlation between the selection advantage of Delta and Omicron at the country level, suggesting that region-specific explanatory variables of fitness differences do exist. Our method is implemented in the Stan programming language, can be run on standard commercial-grade computing resources, and should be straightforward to apply to future variants.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种在其相对适应性方面,无论在时间上还是空间上都表现出显著的异质性。在本文中,我们将先前发表的用于估计SARS-CoV-2新变种选择强度的模型扩展为一个分层、混合效应、更新方程模型。这种公式使我们能够在控制复杂传播模式的同时,在不同空间层面全局估计选择效应,并共同推断单位层面协变量对SARS-CoV-2选择效应空间异质性的影响。将该模型应用于奥密克戎在40个县的传播情况,发现在国家层面存在非常强(64%)但非常异质的选择效应的证据。我们进一步考虑了不同的疫苗接种水平衡量指标以及近期人群感染水平衡量指标,作为可能的解释。然而,这些变量均未被发现能够解释国家层面选择效应异质性的很大一部分。我们确实发现,在国家层面,德尔塔和奥密克戎的选择优势之间存在显著的正相关,这表明确实存在特定区域的适应性差异解释变量。我们的方法是用Stan编程语言实现的,可以在标准商业级计算资源上运行,并且应该很容易应用于未来的变种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/75794d0758f9/nihpp-2022.06.15.22276436v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/ffd93e507add/nihpp-2022.06.15.22276436v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/683c457f5b2b/nihpp-2022.06.15.22276436v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/effa84d66b36/nihpp-2022.06.15.22276436v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/75794d0758f9/nihpp-2022.06.15.22276436v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/ffd93e507add/nihpp-2022.06.15.22276436v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/683c457f5b2b/nihpp-2022.06.15.22276436v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/effa84d66b36/nihpp-2022.06.15.22276436v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7304/9216718/75794d0758f9/nihpp-2022.06.15.22276436v1-f0004.jpg

相似文献

1
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron.严重急性呼吸综合征冠状病毒2型奥密克戎变种适应性优势的全球估计。
medRxiv. 2022 Jun 16:2022.06.15.22276436. doi: 10.1101/2022.06.15.22276436.
2
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株奥密克戎适应性优势的全球评估。
Virus Evol. 2022 Oct 7;8(2):veac089. doi: 10.1093/ve/veac089. eCollection 2022.
3
Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.截至2021年12月1日美国各州及县对新冠病毒原始毒株和奥密克戎毒株的群体免疫情况
medRxiv. 2022 Mar 1:2021.12.23.21268272. doi: 10.1101/2021.12.23.21268272.
4
Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.在缓慢和快速流行疫情中选择感染性特征,以及 SARS-CoV-2 变体的出现。
Elife. 2022 May 19;11:e75791. doi: 10.7554/eLife.75791.
5
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant model.2021-22 年法国地区 SARS-CoV-2 奥密克戎对德尔塔入侵的回顾性分析:基于状态的多变量模型。
BMC Infect Dis. 2022 Nov 3;22(1):815. doi: 10.1186/s12879-022-07821-5.
6
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
7
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.SARS-CoV-2 变异株在欧洲国家中的替代数学建模:传播动力学和流行病学见解。
Front Public Health. 2024 May 15;12:1339267. doi: 10.3389/fpubh.2024.1339267. eCollection 2024.
8
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
9
Estimating the strength of selection for new SARS-CoV-2 variants.评估新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的选择强度。
medRxiv. 2021 Sep 24:2021.03.29.21254233. doi: 10.1101/2021.03.29.21254233.
10
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.丹麦的一项观察性队列研究:感染 SARS-CoV-2 奥密克戎变异株与德尔塔变异株导致住院的风险比较。
Lancet Infect Dis. 2022 Jul;22(7):967-976. doi: 10.1016/S1473-3099(22)00154-2. Epub 2022 Apr 22.

本文引用的文献

1
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus.对大学校园里的 SARS-CoV-2 奥密克戎变异株进行基因组监测。
Nat Commun. 2022 Sep 6;13(1):5240. doi: 10.1038/s41467-022-32786-z.
2
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness.分析 640 万例 SARS-CoV-2 基因组,鉴定与适应性相关的突变。
Science. 2022 Jun 17;376(6599):1327-1332. doi: 10.1126/science.abm1208. Epub 2022 May 24.
3
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England.
在英国,SARS-CoV-2 的 Delta 变异株迅速被奥密克戎(B.1.1.529)取代。
Sci Transl Med. 2022 Jul 6;14(652):eabo5395. doi: 10.1126/scitranslmed.abo5395.
4
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
5
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis.阿尔法和德尔塔 SARS-CoV-2 变异株的生成时间:一项流行病学分析。
Lancet Infect Dis. 2022 May;22(5):603-610. doi: 10.1016/S1473-3099(22)00001-9. Epub 2022 Feb 14.
6
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.南非 SARS-CoV-2 奥密克戎变异株的快速流行扩张。
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
7
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.新冠病毒奥密克戎变异株的血浆中和作用
N Engl J Med. 2022 Feb 10;386(6):599-601. doi: 10.1056/NEJMc2119641. Epub 2021 Dec 30.
8
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.
9
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.奥密克戎能广泛但不完全地逃避辉瑞 BNT162b2 的中和作用。
Nature. 2022 Feb;602(7898):654-656. doi: 10.1038/s41586-021-04387-1. Epub 2021 Dec 23.
10
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.BNT162b2疫苗在南非针对奥密克戎变异株的有效性
N Engl J Med. 2022 Feb 3;386(5):494-496. doi: 10.1056/NEJMc2119270. Epub 2021 Dec 29.